http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111450220-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0525d4a21d148461d25678d71b9a9b4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-236 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8968 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-344 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9064 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e9949dae1e79162a7a7249f3ef0790e |
| publicationDate | 2020-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111450220-A |
| titleOfInvention | A traditional Chinese medicine composition for treating coronary heart disease with Qi deficiency and blood stasis syndrome |
| abstract | The invention relates to a traditional Chinese medicine composition for treating coronary heart disease with qi deficiency and blood stasis syndrome, and belongs to the technical field of traditional Chinese medicinal compositions. The traditional Chinese medicine composition of the invention comprises 25-35 parts by weight of Codonopsis Radix, 8-12 parts by weight of Panax notoginseng, 25-35 parts by weight of Astragalus, 25-35 parts by weight of Salvia miltiorrhiza, 8-12 parts by weight of Chuanxiong, 8-12 parts by weight of Rhodiola rosea Parts by weight, 8-12 parts by weight of Corydalis, 8-12 parts by weight of Bupleurum, 8-12 parts by weight of Ophiopogon japonicus, 8-12 parts by weight of Suanzao Ren, 8-12 parts by weight of Schisandra chinensis, 5-7 parts by weight of Fructus 8 to 12 parts by weight of benevolence. The traditional Chinese medicine composition formulation of the invention can obviously interfere with the therapeutic effect and prognosis of coronary heart disease with Qi deficiency and blood stasis syndrome, improve the quality of life of patients, has high clinical application value, and is worthy of further research and promotion. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115869355-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114848744-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114848744-B |
| priorityDate | 2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.